Northern Trust Corp Atea Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 687,438 shares of AVIR stock, worth $2.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

687,438

Previous 661,284 3.96%

Holding current value

$2.19 Million

Previous $2.19 Million 5.21%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.17 - $4.02 $82,908 - $105,139	26,154 Added 3.96%	687,438 $2.3 Million
Q2 2024 Aug 14, 2024	SELL	$3.31 - $4.04 $86,010 - $104,979	-25,985 Reduced 3.78%	661,284 $2.19 Million
Q1 2024 May 14, 2024	SELL	$3.09 - $4.56 $74,913 - $110,552	-24,244 Reduced 3.41%	687,269 $2.78 Million
Q4 2023 Feb 13, 2024	BUY	$2.8 - $3.35 $127,010 - $151,959	45,361 Added 6.81%	711,513 $2.17 Million
Q3 2023 Nov 13, 2023	BUY	$3.0 - $3.79 $58,227 - $73,560	19,409 Added 3.0%	666,152 $2 Million
Q2 2023 Aug 11, 2023	SELL	$3.21 - $5.06 $187,146 - $295,003	-58,301 Reduced 8.27%	646,743 $2.42 Million
Q1 2023 May 15, 2023	SELL	$3.0 - $4.97 $17,682 - $29,293	-5,894 Reduced 0.83%	705,044 $2.36 Million
Q4 2022 Feb 13, 2023	SELL	$4.35 - $6.17 $62,152 - $88,156	-14,288 Reduced 1.97%	710,938 $3.42 Million
Q3 2022 Nov 14, 2022	BUY	$5.49 - $8.79 $176,229 - $282,159	32,100 Added 4.63%	725,226 $4.13 Million
Q2 2022 Aug 12, 2022	BUY	$5.33 - $8.18 $709,454 - $1.09 Million	133,106 Added 23.77%	693,126 $4.92 Million
Q1 2022 May 13, 2022	SELL	$5.5 - $9.19 $83,864 - $140,129	-15,248 Reduced 2.65%	560,020 $4.04 Million
Q4 2021 Feb 08, 2022	SELL	$7.67 - $44.59 $123,433 - $717,586	-16,093 Reduced 2.72%	575,268 $5.14 Million
Q3 2021 Nov 15, 2021	BUY	$21.33 - $35.06 $1.51 Million - $2.49 Million	70,939 Added 13.63%	591,361 $20.7 Million
Q2 2021 Aug 13, 2021	BUY	$19.22 - $59.08 $6.79 Million - $20.9 Million	353,262 Added 211.33%	520,422 $11.2 Million
Q1 2021 May 12, 2021	SELL	$41.42 - $88.44 $403,637 - $861,847	-9,745 Reduced 5.51%	167,160 $10.3 Million
Q4 2020 Feb 11, 2021	BUY	$26.36 - $41.78 $4.66 Million - $7.39 Million	176,905 New	176,905 $7.39 Million

Others Institutions Holding AVIR

# of Institutions

112

Shares Held

52.4M

Call Options Held

900

Put Options Held

126K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $266M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Atea Pharmaceuticals, Inc. Transaction History